.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Find suppliers and generic API sources
  • Uncover prior art in expired and abandoned patents

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Deloitte
Citi
Accenture
Chubb
QuintilesIMS
Merck
Chinese Patent Office
Baxter
Mallinckrodt
Julphar

Generated: July 26, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 021286

« Back to Dashboard
NDA 021286 describes BENICAR, which is a drug marketed by Daiichi Sankyo and is included in two NDAs. It is available from nine suppliers. There is one patent protecting this drug and three Paragraph IV challenges. Additional details are available on the BENICAR profile page.

The generic ingredient in BENICAR is hydrochlorothiazide; olmesartan medoxomil. There are thirty-one drug master file entries for this compound. Thirteen suppliers are listed for this compound. Additional details are available on the hydrochlorothiazide; olmesartan medoxomil profile page.

Summary for NDA: 021286

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:1
Therapeutic Class:Cardiovascular Agents
Formulation / Manufacturing:see details

Pharmacology for NDA: 021286

Suppliers and Packaging for NDA: 021286

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
BENICAR
olmesartan medoxomil
TABLET;ORAL 021286 NDA Lake Erie Medical & Surgical Supply DBA Quality Care Products LLC 35356-216 35356-216-30 30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (35356-216-30)
BENICAR
olmesartan medoxomil
TABLET;ORAL 021286 NDA Lake Erie Medical & Surgical Supply DBA Quality Care Products LLC 35356-216 35356-216-90 90 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (35356-216-90)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength5MG
Approval Date:Apr 25, 2002TE:ABRLD:Yes
Patent:► SubscribePatent Expiration:Oct 25, 2016Product Flag?Substance Flag?Delist Request?

Summary for product number 003

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength20MG
Approval Date:Apr 25, 2002TE:ABRLD:Yes
Patent:► SubscribePatent Expiration:Oct 25, 2016Product Flag?Substance Flag?Delist Request?

Summary for product number 004

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength40MG
Approval Date:Apr 25, 2002TE:ABRLD:Yes
Patent:► SubscribePatent Expiration:Oct 25, 2016Product Flag?Substance Flag?Delist Request?

Expired Orange Book Patents for NDA: 021286

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Daiichi Sankyo
BENICAR
olmesartan medoxomil
TABLET;ORAL021286-001Apr 25, 2002► Subscribe► Subscribe
Daiichi Sankyo
BENICAR
olmesartan medoxomil
TABLET;ORAL021286-004Apr 25, 2002► Subscribe► Subscribe
Daiichi Sankyo
BENICAR
olmesartan medoxomil
TABLET;ORAL021286-003Apr 25, 2002► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.



Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

US Army
Covington
Chinese Patent Office
Argus Health
Federal Trade Commission
Medtronic
McKesson
Mallinckrodt
Fuji
Citi

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot